309 related articles for article (PubMed ID: 23295949)
1. Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice.
Benkhelifa-Ziyyat S; Besse A; Roda M; Duque S; Astord S; Carcenac R; Marais T; Barkats M
Mol Ther; 2013 Feb; 21(2):282-90. PubMed ID: 23295949
[TBL] [Abstract][Full Text] [Related]
2. Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates.
Meyer K; Ferraiuolo L; Schmelzer L; Braun L; McGovern V; Likhite S; Michels O; Govoni A; Fitzgerald J; Morales P; Foust KD; Mendell JR; Burghes AH; Kaspar BK
Mol Ther; 2015 Mar; 23(3):477-87. PubMed ID: 25358252
[TBL] [Abstract][Full Text] [Related]
3. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.
Dominguez E; Marais T; Chatauret N; Benkhelifa-Ziyyat S; Duque S; Ravassard P; Carcenac R; Astord S; Pereira de Moura A; Voit T; Barkats M
Hum Mol Genet; 2011 Feb; 20(4):681-93. PubMed ID: 21118896
[TBL] [Abstract][Full Text] [Related]
4. Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy.
Passini MA; Bu J; Richards AM; Treleaven CM; Sullivan JA; O'Riordan CR; Scaria A; Kells AP; Samaranch L; San Sebastian W; Federici T; Fiandaca MS; Boulis NM; Bankiewicz KS; Shihabuddin LS; Cheng SH
Hum Gene Ther; 2014 Jul; 25(7):619-30. PubMed ID: 24617515
[TBL] [Abstract][Full Text] [Related]
5. Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice.
Rashnonejad A; Amini Chermahini G; Gündüz C; Onay H; Aykut A; Durmaz B; Baka M; Su Q; Gao G; Özkınay F
Mol Ther; 2019 Dec; 27(12):2123-2133. PubMed ID: 31543414
[TBL] [Abstract][Full Text] [Related]
6. AAV9-Mediated Expression of SMN Restricted to Neurons Does Not Rescue the Spinal Muscular Atrophy Phenotype in Mice.
Besse A; Astord S; Marais T; Roda M; Giroux B; Lejeune FX; Relaix F; Smeriglio P; Barkats M; Biferi MG
Mol Ther; 2020 Aug; 28(8):1887-1901. PubMed ID: 32470325
[TBL] [Abstract][Full Text] [Related]
7. A large animal model of spinal muscular atrophy and correction of phenotype.
Duque SI; Arnold WD; Odermatt P; Li X; Porensky PN; Schmelzer L; Meyer K; Kolb SJ; Schümperli D; Kaspar BK; Burghes AH
Ann Neurol; 2015 Mar; 77(3):399-414. PubMed ID: 25516063
[TBL] [Abstract][Full Text] [Related]
8. Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy.
Reilly A; Deguise MO; Beauvais A; Yaworski R; Thebault S; Tessier DR; Tabard-Cossa V; Hensel N; Schneider BL; Kothary R
Gene Ther; 2022 Sep; 29(9):544-554. PubMed ID: 35462564
[TBL] [Abstract][Full Text] [Related]
9. PTEN depletion decreases disease severity and modestly prolongs survival in a mouse model of spinal muscular atrophy.
Little D; Valori CF; Mutsaers CA; Bennett EJ; Wyles M; Sharrack B; Shaw PJ; Gillingwater TH; Azzouz M; Ning K
Mol Ther; 2015 Feb; 23(2):270-7. PubMed ID: 25369768
[TBL] [Abstract][Full Text] [Related]
10. Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy.
Glascock JJ; Shababi M; Wetz MJ; Krogman MM; Lorson CL
Biochem Biophys Res Commun; 2012 Jan; 417(1):376-81. PubMed ID: 22172949
[TBL] [Abstract][Full Text] [Related]
11. Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders.
Bevan AK; Duque S; Foust KD; Morales PR; Braun L; Schmelzer L; Chan CM; McCrate M; Chicoine LG; Coley BD; Porensky PN; Kolb SJ; Mendell JR; Burghes AH; Kaspar BK
Mol Ther; 2011 Nov; 19(11):1971-80. PubMed ID: 21811247
[TBL] [Abstract][Full Text] [Related]
12. Defining the therapeutic window in a severe animal model of spinal muscular atrophy.
Robbins KL; Glascock JJ; Osman EY; Miller MR; Lorson CL
Hum Mol Genet; 2014 Sep; 23(17):4559-68. PubMed ID: 24722206
[TBL] [Abstract][Full Text] [Related]
13. AAV9-Stathmin1 gene delivery improves disease phenotype in an intermediate mouse model of spinal muscular atrophy.
Villalón E; Kline RA; Smith CE; Lorson ZC; Osman EY; O'Day S; Murray LM; Lorson CL
Hum Mol Genet; 2019 Nov; 28(22):3742-3754. PubMed ID: 31363739
[TBL] [Abstract][Full Text] [Related]
14. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN.
Foust KD; Wang X; McGovern VL; Braun L; Bevan AK; Haidet AM; Le TT; Morales PR; Rich MM; Burghes AH; Kaspar BK
Nat Biotechnol; 2010 Mar; 28(3):271-4. PubMed ID: 20190738
[TBL] [Abstract][Full Text] [Related]
15. Interaction between alpha-COP and SMN ameliorates disease phenotype in a mouse model of spinal muscular atrophy.
Custer SK; Astroski JW; Li HX; Androphy EJ
Biochem Biophys Res Commun; 2019 Jun; 514(2):530-537. PubMed ID: 31060774
[TBL] [Abstract][Full Text] [Related]
16. Decreasing disease severity in symptomatic, Smn(-/-);SMN2(+/+), spinal muscular atrophy mice following scAAV9-SMN delivery.
Glascock JJ; Osman EY; Wetz MJ; Krogman MM; Shababi M; Lorson CL
Hum Gene Ther; 2012 Mar; 23(3):330-5. PubMed ID: 22029744
[TBL] [Abstract][Full Text] [Related]
17. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.
Hua Y; Sahashi K; Rigo F; Hung G; Horev G; Bennett CF; Krainer AR
Nature; 2011 Oct; 478(7367):123-6. PubMed ID: 21979052
[TBL] [Abstract][Full Text] [Related]
18. Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy.
Valori CF; Ning K; Wyles M; Mead RJ; Grierson AJ; Shaw PJ; Azzouz M
Sci Transl Med; 2010 Jun; 2(35):35ra42. PubMed ID: 20538619
[TBL] [Abstract][Full Text] [Related]
19. Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration.
Arnold WD; Duque S; Iyer CC; Zaworski P; McGovern VL; Taylor SJ; von Herrmann KM; Kobayashi DT; Chen KS; Kolb SJ; Paushkin SV; Burghes AH
PLoS One; 2016; 11(12):e0167077. PubMed ID: 27907033
[TBL] [Abstract][Full Text] [Related]
20. Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice.
de la Fuente S; Sansa A; Periyakaruppiah A; Garcera A; Soler RM
Mol Neurobiol; 2019 Jun; 56(6):4414-4427. PubMed ID: 30327977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
